SUN Pharmaceutical Industries Limited Atorvastatin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Atorvastatin Export Records India — #8 Exporter, 1,299 Shipments, $32.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

SUN Pharmaceutical Industries Limited — Atorvastatin Exporter #8 | $32.8M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Atorvastatin Exporter Profile

Indian Pharmaceutical Exporter · #8 for Atorvastatin · $32.8M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #8 Indian exporter of Atorvastatin with $32.8M in export value and 1,299 verified shipments. SUN Pharmaceutical Industries Limited holds a 3.0% market share in Atorvastatin exports across 18 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Atorvastatin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Atorvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Atorvastatin?

Country	Value	Shipments	Share
BELGIUM	$16.2M	776	47.9%
AUSTRALIA	$12.2M	476	36.0%
SOUTH AFRICA	$1.9M	117	5.7%
MYANMAR	$1.1M	25	3.2%
OMAN

Who Are the Top Buyers of Atorvastatin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$15.5M	758
SUN PHARMA ANZ PTY LTD.	AUSTRALIA	$4.8M	201
SUN PHARMA ANZ PTY LTD	AUSTRALIA	$2.9M	99
SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$2.5M	102
M/S. SUN PHARMA ANZ PTY LTD	AUSTRALIA	$1.4M	52
RANBAXY PHARMACEUTICALS PTY LTD.,	SOUTH AFRICA	$882.0K	65
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$609.7K	14
M S SUN PHARMA ANZ PTY LTD	AUSTRALIA	$419.6K	12
RANBAXY PHARMACEUTICALS PTY LIMITED	SOUTH AFRICA	$405.4K	20
RANBAXY SOUTH AFRICA PTY LTD	SOUTH AFRICA	$365.5K	20

SUN Pharmaceutical Industries Limited supplies Atorvastatin to 83 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by SUN PHARMA ANZ PTY LTD. (AUSTRALIA) and SUN PHARMA ANZ PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Atorvastatin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
ATORVASTATIN CALCIUM TABLETS 20MG ( ATOR	$1.0M	48
ATORVASTATIN CALCIUM TABLETS 20MG ( ATORVASTATIN SUN FC TAB 20MG ) EACH FILM-COATED TABLET CONTAINS: ATORVASTATIN CALCIU	$949.0K	77
ATORVASTATIN CALCIUM TABLETS 40MG ( ATOR	$878.7K	35
ATORVASTATIN SZ 40MG EACH FILM COATED TA	$687.7K	16
ATORVASTATIN CALCIUM TABLETS 80MG ( ATOR	$597.1K	13
ATORVASTATIN CALCIUM TABLETS 10MG ( ATOR	$579.1K	25
APO ATORVASTATIN TAB 20 mg: EACH FILM CO	$564.1K	12
APO ATORVASTATIN TAB 40 mg: EACH FILM CO	$488.3K	17
ATORVASTATIN CALCIUM TABLETS 40MG ( ATORVASTATIN SUN FC TAB 40MG ) EACH FILM-COATED TABLET CONTAINS: ATORVASTATIN CALCIU	$483.4K	16
ATORVASTATIN SZ 80MG EACH FILM COATED TA	$451.2K	11

SUN Pharmaceutical Industries Limited exports 684 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN CALCIUM TABLETS 20MG ( ATOR with 48 shipments worth $1.0M.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Atorvastatin Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	MSN LABORATORIES PRIVATE LIMITED	$83.7M	3,224	20	$26.0K
7	AUROBINDO PHARMA LTD	$33.2M	879	11	$37.7K
8	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$32.8M	1,299	18	$25.3K
9	GRAVITI PHARMACEUTICALS PRIVATE LIMITED	$24.0M	664	1	$36.1K
2	PIRAMAL PHARMA LIMITED	$21.4M	429	1	$50.0K

SUN Pharmaceutical Industries Limited ranks #8 among 477 Indian Atorvastatin exporters. Average shipment value of $25.3K compared to the market average of $657.7K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and AUROBINDO PHARMA LTD.

Which Indian Ports Ship Atorvastatin Exports?

Port	Shipments	% Share
HYDERABAD ICD	2,042	13.6%
HYDERABAD ICD (INSNF6)	1,131	7.5%
NHAVA SHEVA SEA (INNSA1)	842	5.6%
SAHAR AIR	839	5.6%
JNPT/ NHAVA SHEVA SEA	779	5.2%
DELHI AIR	613	4.1%
SAHAR AIR CARGO ACC (INBOM4)	581	3.9%
HYDERABAD AIR	554	3.7%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Atorvastatin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,554 individual customs records matching SUN Pharmaceutical Industries Limited exporting Atorvastatin, covering 684 formulations to 19 countries via 83 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 1,291+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atorvastatin

Atorvastatin

SUN Pharmaceutical Industries Limited — Atorvastatin Exporter Profile

SUN Pharmaceutical Industries Limited — Atorvastatin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Atorvastatin?

Who Are the Top Buyers of Atorvastatin from SUN Pharmaceutical Industries Limited?

What Is India's Total Atorvastatin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Atorvastatin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Atorvastatin Exporters?

What Atorvastatin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Atorvastatin to Key Markets

Australia — TGA

South Africa — SAHPRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Atorvastatin Exporters?

Which Indian Ports Ship Atorvastatin Exports?

What Other Cardiovascular Products Does SUN Pharmaceutical Industries Limited Export?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Atorvastatin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atorvastatin Export Data from SUN Pharmaceutical Industries Limited

Atorvastatin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source